Ipamorelin 10mg Selective Growth Hormone Secretagogue | GH Pulse Research Peptide
Ipamorelin 10mg Selective Growth Hormone Secretagogue | GH Pulse Research Peptide
Ipamorelin 10mg Selective Growth Hormone Secretagogue | GH Pulse Research Peptide
Overview Ipamorelin is a synthetic pentapeptide and one of the most selective growth hormone secretagogues developed to date. The 10mg presentation is engineered for advanced research into pulsatile GH release, somatotropic signalling, and recovery-related endocrine pathways — offering a clean, targeted profile distinct from earlier-generation GHRPs.
Mechanism of Interest Ipamorelin acts as a selective agonist of the ghrelin / growth hormone secretagogue receptor (GHS-R1a), stimulating physiological release of growth hormone from the anterior pituitary. Unlike less selective secretagogues (such as GHRP-2 and GHRP-6), Ipamorelin is widely studied for its clean release profile — minimal interaction with cortisol, prolactin, or aldosterone pathways — making it a refined tool for research focused exclusively on GH dynamics.
Product Specifications
- Product Name: Ipamorelin 10mg
- Catalogue Reference: IPA10-024
- Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
- Molecular Formula: C₃₈H₄₉N₉O₅
- Molecular Weight: 711.86 g/mol
- Purity: ≥98% (HPLC verified)
- Presentation: Lyophilised solid
- Storage: -20°C
Research Applications Ipamorelin is utilised across endocrinology, recovery science, body composition, and longevity research — particularly in studies investigating pulsatile GH and IGF-1 dynamics, sleep-phase GH release, lean tissue and recovery models, and age-related somatotropic decline. Its receptor selectivity makes it a preferred research tool where isolation of GH-axis effects is essential.
Synergistic Research Context Ipamorelin is frequently studied alongside CJC-1295 (with or without DAC) in dual-peptide research models. The combination of a selective GHRP (Ipamorelin) with a GHRH analogue (CJC-1295) is one of the most extensively explored pairings in GH-axis research — investigated for its complementary action on both pulse amplitude and pulse frequency of growth hormone release.
Quality & Handling Synthesised under controlled laboratory conditions and supplied as a lyophilised solid for maximum stability. Reconstitution with appropriate bacteriostatic solution is required prior to use in any research model. Every batch is subjected to rigorous quality control to ensure ≥98% purity, identity, and reproducibility.
Compliance Statement All Asclepius peptide products are supplied strictly for laboratory research purposes. They are not intended for human consumption, diagnosis, treatment, or therapeutic use. Enquiries relating to human application cannot be supported.
Order with Confidence Asclepius peptides are sourced, tested, and dispatched to a clinical standard — built for researchers and practitioners who refuse to compromise on integrity, purity, or precision.
For technical specifications, certificates of analysis, or research support, our team is available to assist.